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ABSTRACT Each cell type responds uniquely to stress and fractionally contributes to global and tissue-specific stress 
responses. Hepatocytes, liver macrophages (MΦ), and sinusoidal endothelial cells (SEC) play functionally important 
and interdependent roles in adaptive processes such as obesity and tumor growth. Although these cell types demon-
strate significant phenotypic and functional heterogeneity, their distinctions enabling disease-specific responses remain 
understudied. We developed a strategy for the simultaneous isolation and quantification of these liver cell types based 
on antigenic cell surface marker expression. To demonstrate the utility and applicability of this technique, we quantified 
liver cell-specific responses to high-fat diet (HFD) or diethylnitrosamine (DEN), a liver-specific carcinogen, and found 
that while there was only a marginal increase in hepatocyte number, MΦ and SEC populations were quantitatively 
increased. Global gene expression profiling of hepatocytes, MΦ and SEC identified characteristic gene signatures that 
define each cell type in their distinct physiological or pathological states. Integration of hepatic gene signatures with 
available human obesity and liver cancer microarray data provides further insight into the cell-specific responses to 
metabolic or oncogenic stress. Our data reveal unique gene expression patterns that serve as molecular “fingerprints” 
for the cell-centric responses to pathologic stimuli in the distinct microenvironment of the liver. The technical advance 
highlighted in this study provides an essential resource for assessing hepatic cell-specific contributions to metabolic and 
oncogenic stress, information that could unveil previously unappreciated molecular mechanisms for the cellular crosstalk 
that underlies the continuum from metabolic disruption to obesity and ultimately hepatic cancer.
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INTRODUCTION
The liver coordinately regulates essential aspects of whole-body me-
tabolism, detoxification, and macromolecular synthesis/breakdown. Its 
architectural infrastructure is composed of small hexagonal lobules, with 
each lobule connected by a network of sinusoids formed by specialized 
SEC. In turn, each sinusoid traverses a collection of two primary cell 
types: hepatocytes (PH), which compose the bulk of liver tissue, and 
Kupffer cells (MΦ) [1]. Although these cell types demonstrate significant 
phenotypic and functional heterogeneity, their molecular contributions 
to metabolic stress and hepatic cancer remain understudied.
Obesity shares aspects of its clinical epidemiology with hepatocellular 
cancer (HCC), and is considered to be a predisposing risk factor for this 
type of hepatic cancer [2-4]. Both obesity and HCC are characterized 
by heightened inflammatory responses that perturb hepatocyte func-
tion and promote their transformation [2,4,5]. The presence of tumor 
myeloid infiltrates is a negative indicator for liver cancer prognosis, 
as MΦ secrete cytokines that facilitate the inflammatory response and 
ultimately promote tumor growth [6]. Hypervascularization is a hall-
mark of HCC, underscoring the role of angiogenesis and altered SEC 
function during hepatocarcinogenesis [7].
Today’s OMICs age of biological and clinical research employs 
data integration to determine prognostic signatures or identify putative 
therapeutic targets. Contributions of individual and underrepresented 
cell types to the molecular signature of a disease are often overlooked, 
since OMICs datasets are usually obtained from composite samples 
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of the tissue of interest. While a recent study generated proteomic 
data from individual liver cell types [8], no other study has reported 
in-depth transcriptomic analyses on individual hepatic cell types with a 
particular focus on determining cell-specific responses to pathological 
stimuli such as metabolic and oncogenic stress.
Thus, we developed a molecularly validated, multiple antigen-based 
method by which CD95+ PH, F4/80+CD45+ MΦ and vascular endothe-
lial-cadherin (VE-cad)+CD45- SEC can be simultaneously isolated and 
their transcriptomic signatures compared under physiological versus 
pathological conditions. Earlier efforts to isolate these 3 cell types 
generally employed crude enzymatic digestion of the liver, followed 
by centrifugation to fractionate the resulting cell suspension; however 
this technique yields impure cell preparations, especially for the pa-
renchymal fraction [9]. Only recently have reports of antigen-based 
strategies emerged wherein magnetic-activated cell sorting (MACS) 
for Kupffer cells and liver SEC was used to improve the purity of these 
cell preparations from the parenchymal cell type [8,10]. One major 
hindrance in developing an antigen-based strategy for co-isolation of 
hepatocytes, MΦ and SEC has been the controversial characterization 
of their cell-specific phenotypes. Our initial assessment of cell surface 
marker expression by each of these cell types in the murine liver was 
the foundation of our technique that yields relatively pure, reproducible, 
phenotypically- and functionally-defined cell preparations for subsequent 
downstream analyses.
As proof-of-principle, we utilized this method to qualitatively compare 
the PH-, MΦ-, and SEC-specific molecular responses to metabolic and 
oncogenic insults in the liver in vivo. We found negligible changes in PH 
number upon exposure of the liver to either HFD or DEN. However, liver 
resident MΦ and SEC populations were notably increased in response 
to both stressors. Transcriptomic analyses identified characteristic gene 
“signatures” that define each cell type and their distinct tissue-specific 
biologies under physiological or pathological stress conditions, and also 
permitted direct comparison of murine-versus-human gene expression 
data for clinically relevant applications. The ability to isolate relatively 
pure populations of viable PH, MΦ and SEC provides an indispensable, 
multidisciplinary tool for assessing their unique functions, molecular 
properties and behavior within distinct tissue-specific microenviron-
ments. Collectively, these efforts are critical to improve our understanding 
of the molecular basis for the initiation and progression of metabolic 
and oncogenic diseases.
MATERIALS AND METHODS
Animal care
All experiments were performed in accordance with the Animal 
Care Research Committee at Baylor College of Medicine. All mice 
were on a pure C57BL6/J background, maintained at 23°C with 12 h 
light/dark cycle and fed 2920X Teklad Global rodent chow ad libitum.
Liver perfusion and separation of parenchymal from 
non-parenchymal cell fractions
Liver perfusion and cell separation was performed essentially as 
described in [11], with modifications as outlined in Figure 1B. Livers 
from adult C57BL/6 (wild type, WT) male mice were first perfused with 
phosphate-buffered saline (PBS), then with 0.28 mg/ml collagenase 
IV (Sigma-Aldrich, St. Louis, MO) via retrograde cannulation of the 
inferior vena cava and egress through the portal vein [12]. The result-
ing cell suspension was passed through a 70 µm cell strainer, and then 
centrifuged at 50 × g for 2 min at 4°C. The pellet was resuspended in a 
25:12 mixture of Wash/Plating medium (William's Medium E containing 
50 IU Penicillin-Streptomycin, 25 mg Glutamine/Gentamycin, 5 mg 
Insulin-Transferrin-Selenium [ITS], 2 µg Glucagon, 250 µg Ampho-
tericin B, and 10% fetal bovine serum [FBS]), and 100% Percoll (GE 
Healthcare Life Sciences, Piscataway, NJ) solution, and then centrifuged 
at 50 × g and 4°C for 10 min. An additional wash step was performed 
at 50 × g and 4°C for 2 min using Wash/Plating medium to pellet out 
the parenchymal fraction (Fig. 1B) that is enriched for PH. Supernatant 
fluid from the first wash step was centrifuged three more times at 50 
× g and 4°C for 3 min to eliminate contaminating hepatocytes from 
non-parenchymal cells that remain in suspension. The non-parenchymal 
fractions containing SEC and MΦ from up to four mice were pooled 
and pelleted by centrifugation at 400 × g and 4°C for 10 min.
MACS separation of CD45+ and CD45- fractions and 
FACS isolation of hepatic macrophages and sinusoidal 
endothelial cells
Hepatic non-parenchymal cell pellets were resuspended in 1 × BD 
Pharm Lyse (BD Biosciences, San Jose, CA) red blood cell lysing 
solution for 5 min at RT. HBSS/10% FBS was added to the cell sus-
pension, followed by centrifugation at 400 × g and 4°C for 10 min. 
The resulting cell pellet was resuspended in 90 µl of de-gassed MACS 
buffer containing PBS, 0.5% BSA, and 2 mM EDTA per 107 total cells. 
Cells were then magnetically labeled with CD45 micro-beads (Miltenyi 
Biotec Inc., Auburn, CA) per the manufacturer’s specifications. Using 
an appropriate MACS column (Miltenyi Biotec Inc., San Diego, CA) 
in the magnetic field of a VarioMACS separator (Miltenyi Biotec 
Inc.), the CD45+ cell fraction (eluate) was physically separated from 
the CD45- fraction (flow-through) (Fig. 1B). To ensure depletion of 
CD45-expressing cells, the CD45- flow-through was subjected to an 
additional purification step using a second MACS column. In lieu of an 
FcR blocking step, 0.5% BSA in the MACS buffer and 10% FBS in the 
HBSS buffer were used as non-specific blocking agents as previously 
described (Fig. S1A) [13,14].
CD45+ and CD45- cell fractions were pelleted via centrifugation at 
400 × g and 4°C for 10 min. Cells were resuspended in HBSS/10% FBS 
to a concentration of 108 cells/ml, and subsequently stained with various 
combinations of the following rat anti-mouse antibody conjugates (Ta-
ble S1): VE-cad-eFluor 450, CD45-eFluor 780, CD31-APC, Flk1-PE, 
CD146-FITC, F4/80-PE, CD11b-PE-Cy7, and CD105/Endoglin-PE 
(1:100; eBioscience, San Diego, CA). Single cell suspensions were 
washed and resuspended in HBSS/10% FBS with 10 µg/ml propidium 
iodide (PI; Sigma-Aldrich) for dead cell discrimination, followed by 
flow cytometry and fluorescence-activated cell sorting (FACS) using 
a FACSAria (BD Biosciences) cell sorter (Fig. 1B). Contamination of 
target cell populations by other cell types was also assessed and shown 
in Figure S1B.
MACS/FACS selection and analysis of CD95+ primary 
hepatocytes cell surface markers
Enrichment for primary hepatocytes (PH) was performed by re-
suspending the liver parenchymal fraction in HBSS/10%FBS at 107 
cells/ml, followed by incubation with CD95-Biotin conjugate (1:100, 
eBioscience) for 30 min at 4°C. Excess unbound primary antibody was
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Figure 1. Cell type-specific antigenic marker-based protocol for simultaneous tissue-specific isolation of PH, MΦ, and SEC from murine liver. 
A. H&E stained paraffin-embedded sections of normal murine liver revealing normal endogenous tissue architecture in vivo [i]. The relationship between 
PH, MΦ, and SEC is highlighted in the accompanying schematic [ii]. Scale bars = 20 μm. See Table S3 for corresponding image magnification.  B. 
Flowchart outlining experimental strategy for simultaneous isolation of PH, MΦ, and SEC.
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removed via washing and centrifugation at 400 × g for 10 min at 4ºC; 
the resulting cell pellet was resuspended in 90 µl of de-gassed MACS 
buffer/107 total cells, followed by magnetic labeling with Anti-Biotin 
micro-beads (Miltenyi Biotec Inc., Auburn, CA) per the manufacturer’s 
specifications. Magnetic separation was performed using an appropri-
ate MACS column in the magnetic field of a VarioMACS separator, 
with CD95-expressing primary hepatocytes collected as eluate (Fig. 
1B). Hepatocytes were assessed for cell surface marker expression by 
staining with the following rat anti-mouse antibody conjugates (Table 
S1): CD95-APC, EpCAM/CD326-PE-Cy7, CD45-eFluor 780, and 
c-Kit-PE (1:100; eBioscience). Single cell suspensions were washed 
at 50 × g and 4°C for 3 min, and resuspended in HBSS/10% FBS with 
10 µg/ml PI, followed by flow cytometry using a FACSAria cell sorter.
High fat diet (HFD) and diethylnitrosamine (DEN) stud-
ies
Adult male C57BL/6 mice subjected to 10 weeks of HFD upon 
weaning were purchased from Jackson Laboratories (Bar Harbor, 
ME). For DEN studies, 10 male WT mice were injected intraperito-
neally with 25 mg/kg DEN (in DMSO) (Sigma) at post-natal day 15. 
Tumor progression was monitored for 9 months post-injection. Mice 
were sacrificed, and livers isolated and manually quantified for tumor 
burden using a standard micrometer. Untreated C57BL/6 male mice 
age-matched to HFD-treated or DEN-treated mice were sacrificed at 
the same time, and their livers harvested as described above.
Cell culture
Cell viability was assessed via trypan blue exclusion. PH (106 cells) 
were seeded in 10 cm pre-coated tissue culture plates (BD Primaria™, 
BD Biosciences) in Wash/Plating Medium as described above, allowed 
to attach overnight, followed by a medium change 24 h post-seeding. 
F4/80+ resident MΦ were FACS-sorted directly onto 6-well pre-coated 
tissue culture plates (50,000 cells/well; BD Primaria™, BD Bioscienc-
es) in Dulbecco's Modified Eagle's Medium (DMEM) with 10% FBS. 
VE-cad+CD45- SEC were FACS-sorted directly onto fibronectin-coated 
48-well tissue culture plates (2,000 cells/well) in Endothelial Cell 
Growth Medium-2 (EGM-2; Lonza Inc., Allendale, NJ). All cultures 
were incubated at 37ºC with 5% CO2 and observed daily.
Oil red O
PH in culture were rinsed with PBS and then fixed with 10% neutral 
buffered formalin for 30 min at RT. After washing twice with deion-
ized water, 60% isopropanol was applied to the fixed cells for 5 min, 
followed by a freshly prepared working solution of 1.5 mg/ml Oil Red 
O in isopropanol for 5 min at RT. The stained, fixed cells were then 
rinsed with tap water until clear, covered with tap water and viewed 
on a phase contrast microscope.
LPS treatment of macrophages
MΦ isolated from the liver were cultured in DMEM/F12 supplemented 
with 10% FBS for 2 days. On the third day, medium was refreshed with 
or without supplementation with 100 ng/ml LPS (Sigma, L2654). Cells 
were manually scraped and harvested by centrifugation at 1500 rpm for 
5 min after 3 h incubation. Cell pellets were washed twice with PBS 
(Ca2+/Mg2+ free) and used directly for RNA isolation.
Methylcellulose hematopoietic colony-forming assay
To assess the hematopoietic potential of hepatic MΦ and SEC, F4/80+ 
and VE-cad+CD45- cells were isolated by FACS and sorted directly into 
250 µl of MethoCult GF M3434 hematopoietic cell culture medium 
(StemCell Technologies, Vancouver, BC) in fibronectin-coated 48-well 
tissue culture plates (BD BioCoat™, BD Biosciences). All cultures were 
incubated at 37ºC with 5% CO2, and scored for colony formation at 
days 1, 3, 5, and 7 as previously described [15].
Tube formation assay
Ten microliter of Matrigel basement membrane matrix (BD Biosci-
ences) was applied per inner well of a 15-well Angiogenesis µ-Slide 
(ibidi, Planegg, Germany), and allowed to polymerize by incubating at 
37°C for at least 30 min. SEC were suspended in Endothelial Growth 
Medium-2 (EGM-2; Lonza, Basel, Switzerland) at a concentration of 
1 × 105 cells/ml following isolation by FACS; 50 µl of single-cell sus-
pension was applied per well over polymerized matrix. Cells were then 
incubated at 37°C for 20 h until slides were viewed under a phase-con-
trast microscope.
Reverse transcription, qPCR, and gene expression 
profiling
RNA was isolated from PH, MΦ, and SEC using the Ambion Pure-
link RNA Mini Kit (Life Technologies, Carlsbad, CA) according to the 
manufacturer's protocol. First strand cDNA synthesis was performed 
using Superscript VILO according to the manufacturer’s instructions 
(Life Technologies, Carlsbad, CA). Real-time quantitative PCR was 
carried out using TaqMan Universal PCR Reaction Mix (Applied Life 
Technologies, Carlsbad, CA) with sequence-specific primers and the 
Mouse Universal Probe Library (Roche Applied Science, Indianapolis, 
IN). All gene expression assays were performed in triplicate using at 
least 3 independently isolated RNA samples, and the resulting data 
normalized to endogenous 18S rRNA expression. Primer sequences 
are available upon request.
All microarray data (i.e. untreated (UTR), HFD- and DEN-treated 
PH, MΦ, and SEC) reflect the mean of 3 sets of independent experi-
ments each from a pool of 3–4 mice, respectively. For gene expression 
profiling, total RNA was extracted and purified with the RNeasy Mini 
Kit (Qiagen) per the manufacturer’s instructions. RNA was reverse 
transcribed, and microarray hybridization performed using the Illu-
mina Gene Expression MouseWG-6 v2.0 Expression BeadChip Kit 
at the Laboratory for Translational Genomics at Baylor College of 
Medicine. Microarray scanned images were imported to Illumina® 
GenomeStudio for data quality control, and the transcriptome profile 
data was quartile-normalized by the Bioconductor lumi package [16]. 
Differences in gene expression among samples were inferred utilizing 
the Bioconductor limma package [17] (P < 0.05) and imposing a fold 
change exceeding 1.25X using the R statistical system. All microarray 
data have been uploaded to the Gene Expression Omnibus (GEO) under 
reference number GSE67225 (http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc = GSE67225). 
Tissue preparation for embedding
For OCT embedding, livers were freshly dissected and fixed in 4% 
paraformaldehyde (PFA) overnight at 4ºC. Tissues were washed sev-
eral times in PBS, cryoprotected by sequential overnight incubation at 
4ºC in 15% and 30% sucrose solution, embedded in OCT compound 
(Sakura Finetek USA, Torrance, CA), quick frozen in liquid nitrogen, 
and sectioned at 5 µm.
For paraffin embedding, freshly dissected livers were fixed in 10% 
neutral-buffered formalin overnight at 4ºC. Tissues were washed in 
PBS, stored in 70% ethanol at 4ºC until embedded in paraffin and 
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sectioned at 5 µm.
Immunohistochemical staining
For fluorescence immunohistochemical staining, OCT-embedded 
liver sections were blocked for 4–6 h at RT with NDS blocking medium 
(10% normal donkey serum (NDS)/0.5% bovine serum albumin (BSA) 
in PBS). Sections were washed twice with PBS, and then incubated 
overnight at 4°C with 1:100 dilutions of primary antibodies (Table 
S2) in blocking medium. After several PBS washes, sections were 
incubated for 2–4 h at RT with the appropriate secondary antibodies 
(Table S2) diluted at 1:500 with blocking medium, and mounted using 
Vectashield® Mounting Medium (Vector Laboratories, Burlingame, CA) 
with DAPI as a nuclear counterstain. Images were captured with a Zeiss 
AxioObserver microscope fitted with an AxioCam MRm camera, using 
Zeiss AxioVision version 4.8.2.0 software (Carl Zeiss MicroImaging, 
Thornwood, NY).
For colorimetric immunohistochemical staining, paraffin-embedded 
liver sections were deparaffinized and rehydrated using standard methods. 
Antigen retrieval was performed by incubating sections in 1 × Target 
Retrieval Solution (Dako, Carpinteria, CA) for 10 min at 95°C. Slides 
were allowed to cool for 10 min at RT, and then washed twice with 
PBS for 5 min. Several blocking steps were performed by incubating 
sections in the following solutions: (1) endogenous immunoperoxidase 
blocking using 3% hydrogen peroxide solution for 10 min at RT, (2) 
non-specific blocking using NDS blocking media for 1 h at RT, and 
(3) endogenous biotin blocking using Streptavidin-Biotin Blocking 
Kit (Vector Laboratories) per the manufacturer’s specifications. Tissue 
sections were then incubated overnight at 4°C with primary antibodies 
(Table S2) diluted to 1:100 in 0.2 × NDS blocking medium in TBS with 
0.1% Tween-20. After several PBS washes, sections were incubated 
for 1 h at RT with biotinylated species-specific secondary antibodies 
(Table S2) diluted to 1:1000 in 0.2 × NDS blocking medium. After 
washing with PBS, sections were again incubated for 30 min at RT with 
Pierce High Sensitivity Streptavidin-Labeled Horse Radish Peroxidase 
(Thermo Fisher Scientific Inc., Rockford, IL) diluted at 1:1000 in PBS. 
Colorimetric detection of bound antigens was performed using ImmPACT 
DAB detection reagent (Vector Laboratories, Burlingame, CA) per 
the manufacturer’s specifications. Tissue sections were counterstained 
with hematoxylin, dehydrated and cleared using standard methods, 
and mounted using VectaMount® permanent mounting media (Vector 
Laboratories). Images were captured with a Zeiss AxioObserver micro-
scope fitted with an AxioCam ICc3 color camera, using Zeiss AxioVision 
version 4.8.2.0 software (Carl Zeiss MicroImaging, Thornwood, NY).
For fluorescence immunohistochemistry, deparaffinization, rehy-
dration, and antigen retrieval of paraffin-embedded liver sections were 
performed as described above. Non-specific blocking of sections was 
performed using NDS blocking media for 1 h at RT. Tissue sections 
were then incubated overnight at 4°C with primary antibodies (Table 
S2) diluted to 1:100 in 0.2 × NDS blocking medium in TBS with 
0.1% Tween-20. After several PBS washes, sections were incubated 
for 1 h at RT with appropriate combinations of the following fluoro-
phore-conjugated secondary antibodies diluted to 1:500 in 0.2 × NDS 
blocking medium with 0.1% Tween-20: donkey anti-goat-Alexa Fluor 
594, donkey anti-mouse-Alexa 594, and donkey anti-rat-Alexa Fluor 
488 (BD Biosciences). Tissue sections were stained with DAPI and 
mounted using VectaStain mounting medium (Vector Laboratories). 
Images were captured with a Zeiss AxioObserver microscope fitted 
with an AxioCam MRm camera, using Zeiss AxioVision version 4.8.2.0 
software (Carl Zeiss MicroImaging).
HCC tumor gene signature
We utilized two public HCC datasets [18,19] (GSE14520 and TC-
GA-LIHC (http://cancergenome.nih.gov/)) whose gene signatures were 
partitioned into up- and down-regulated genes.
Obesity signatures
We utilized the following publicly available obesity gene expression 
datasets Greenawalt et al. [20] (GSE24293), Pihlajamäki et al. [21] 
(GSE15653), Ahrens et al. [22] (GSE48452), and Keller et al. [23] 
(GSE10785), deposited at Gene Expression Omnibus (GEO) repository 
(http://www.ncbi.nlm.nih.gov/geo/).
Calculation of gene signature score in obesity and HCC 
patient cohorts
For each public dataset, we replaced the gene expression of each 
gene with the z-score with respect to the specimens available in each 
cohort. For each of the signatures, we computed the sum of z-scores 
for each sample as described previously [24], adding the z-score for 
up-regulated genes and subtracting it for down-regulated genes. Finally, 
for each pair of signatures we plotted the cumulative z-scores on the 
X- and Y-axes, and computed the Pearson Correlation Coefficient R 
and associated p-value using the R statistical system and the Python 
matplotlib library.
Gene set enrichment analysis
Gene Set Enrichment Analysis (GSEA) was carried out using the 
GSEA pre-ranked tool in the GSEA software package [25] to assess the 
degree of similarity among the studied gene signatures. After ranking 
all the genes by fold change, Normalized Enrichment Score (NES) and 
adjusted q-values were computed utilizing the GSEA method, based on 
1000 random permutations. We further determined enriched pathways 
by employing the gene set collections at the Molecular Signature Da-
tabase (MSigDB, http://www.broadinstitute.org/gsea/msigdb/) using a 
hypergeometric distribution (P < 0.05).
RESULTS
Antigen-based protocol for simultaneous isolation of 
hepatocytes, macrophages and SEC
Of the numerous cell types in liver, PH constitute the majority of the 
parenchymal fraction (PF), whereas liver-specific MΦ, and SEC that 
line the microvasculature are found in the non-parenchymal fraction 
(NPF) [1]. Figure 1A [i] shows the cellular architecture of the liver 
in section with an illustration of the spatial relationships between the 
liver cell types phenotypically characterized in this study (Fig. 1A [ii]).
We developed an antigen-based protocol for the simultaneous isolation 
and purification of PH, MΦ and SEC from murine liver with the critical 
benefit of maintaining cell viability (Fig. 1B). Efficient dissociation of 
bulk liver is accomplished by collagenase perfusion through the inferior 
vena cava and egress through the portal vein, followed by separation of 
the hepatocyte-containing PF from the NPF by low-speed centrifugation. 
Isolation of bulk liver tissue is followed by a two-step cellular isolation 
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process, the first involving MACS to separate PH from the PF, and to 
separate hepatic MΦ (CD45+ fraction) from SEC (CD45- fraction). The 
second step utilizes FACS to isolate MΦ from bulk CD45+ fractions 
based on differential expression of F4/80 by MΦ (Fig. 1B, blue box). 
Hepatic SEC are isolated from the bulk CD45- fraction by differential 
expression of VE-cad  (Fig. 1B, red box). Because this isolation strategy 
relies on the combinations of multiple antigenic markers by each target 
cell type, it results in high purity cell preparations, and also allows both 
quantitative and qualitative assessment of each cell type in the liver.
Liver parenchymal fraction is enriched for CD95-ex-
pressing hepatocytes
We improved existing PH isolation strategies [26] by MACS of the 
PF to enrich for PH, which constitutively express low levels of CD95 
[27] (Fig. 1B). Approximately 80% of cells in the PF express CD95 
as demonstrated by flow cytometry (Fig. 2A). A second population of 
smaller cells in the PF are CD95- (Fig. 2A) but were excluded as they 
fail to meet our criteria for PH. Immunostaining for CD95 verifies its 
expression in PH (Fig. 2B [i] and Fig. S2C-E). CD95 is co-expressed 
with canonical intracellular PH markers (i.e. albumin and cytokeratin 8) 
(Fig. S2C and D). The expression of several cell surface markers asso-
ciated with murine hepatocytes within the CD95+ fraction of the PF was 
also assessed via FACS and immunohistochemistry (Fig. S2A and B).
Cultured CD95+ PH displayed morphology of mature hepatocytes, 
with mono- and bi-nuclear cells present, along with lipid accumulation 
as confirmed by Oil Red O staining (Fig. 2C [i-ii]). Expression of he-
patocyte-associated genes was further assessed via qPCR. Consistent 
with immunohistological data, expression of mature PH markers Alb 
and CK8 was enriched in the PH fraction compared to the other two 
cell fractions, along with other hepatocyte-associated genes (Fig. 2D). 
These data demonstrate that our improved method for isolation and 
enrichment of CD95+ cells from the liver PF yields relatively pure cell 
preparation of functional PH.
CD45+ non-parenchymal fractions are enriched for 
F4/80+ macrophages
CD45 is generally regarded as a pan-hematopoietic cell marker [28]. 
We selected three myeloid cell surface antigens, F4/80, CD11b, and 
CD16/32, which are strongly correlated with tissue-resident MΦ [29], 
and compared their expression between the CD45+ and CD45- fractions 
of the liver NPF. All three markers were highly enriched within the 
CD45+ fraction (Fig. 3A and B, Fig. S3A).
Immunohistochemical staining revealed cells closely associated with 
sinusoids and frequently located at bifurcations [1], which strongly 
express F4/80 (Fig. 3C [i]) and CD45 (Fig. 4C [ii]). Co-localization 
of F4/80 with CD45 or CD11b is also evident (Fig. 3C [ii-iii], Fig. 
S3B and C). We therefore define hepatic MΦ as F4/80+CD45+ non-pa-
renchymal cells.
F4/80+CD45+ MΦ are small, spherical cells in culture (Fig. 3C 
[iv]). In methylcellulose, hepatic MΦ displayed in vitro hematopoietic 
colony-forming ability whereas SEC showed no such activity (Fig. 3D 
[i]). Moreover, only lineage-restricted granulocyte-macrophage colo-
nies were formed by MΦ in this assay (Fig. 3D [ii]). Thus, not only is 
hematopoietic colony-forming ability unique to F4/80+CD45+ MΦ, but 
the colony-forming capacity of hepatic MΦ is limited to cells of the 
granulocyte-myeloid lineage. Expression of MΦ-associated genes was 
enriched in liver MΦ assessed via qPCR (Fig. 3E). We also examined 
the effect of LPS on inflammatory gene expression in cultured MΦ and 
found transcripts encoding pro-inflammatory cytokines significantly 
up-regulated (Fig. 3F). Thus, hepatic MΦ displayed canonical gene 
expression and colony-forming activity in vitro, demonstrating that our 
isolation procedure allows antigen-based isolation of relatively pure 
and functionally responsive hepatic MΦ.
CD45- non-parenchymal fractions are enriched for VE-
cad+ sinusoidal endothelial cells
We compared expression of endothelial cell markers (VE-cad, CD31, 
Flk1, CD146, and CD105) between the CD45+ and CD45- subsets of the 
liver NPF (Fig. 4A). Only VE-cad was enriched in the CD45- fraction 
(Fig. 4A). In contrast, common endothelial markers (i.e. CD31, Flk1, 
CD105, CD146) were also expressed by cells in the CD45+ fraction (Fig. 
4A). CD45+ cells of hematopoietic origin (i.e. circulating monocytes) 
can express CD31 and Flk1 [30], while expression of CD146, a marker 
commonly used to define and isolate liver SEC [8,10] is reported in 
mesenchymal cells [31]. CD105, on the other hand, is expressed by 
many hematopoietic cells, including CD45- erythrocytes [32]. Examining 
various combinations of endothelial markers, we found that only a small 
fraction of hepatic CD45- cells express SEC markers such as VE-cad, 
CD31 (Fig. 4B [i]), and Flk1 (Fig. S4A). In contrast, over half of VE-
cad+ NPF cells co-express CD31 and Flk1, while a smaller fraction of 
hepatic VE-cad+ cells co-express CD146 (Fig. 4B [ii]).
In situ, VE-cad+ cells line the hepatic sinusoids and even some 
larger vessels (Fig. 4C [i]). Such structures lack CD45 expression 
(Fig. 4C [ii]), consistent with our findings on endothelial cell surface 
marker expression analyzed by FACS. Co-expression of VE-cad was 
observed with CD31 (Fig. 4C [iii]; and Fig. S4B) and Flk1 (Fig. S4C). 
Furthermore, some VE-cad+ cells fail to co-express either CD31 (Fig. 
4C [iii]) or Flk1 (Fig. S4C), demonstrating correlation of our immu-
nohistochemical characterization with FACS analysis of hepatic SEC 
phenotypes, which we define as VE-cad+CD45- non-parenchymal cells.
VE-cad+CD45- cells displayed characteristic cobblestone endothelial 
morphology when cultured on fibronectin (Fig. 4C [iv]). Expression of 
SEC-associated genes were significantly enriched in SEC but negligibly 
expressed by PH or MΦ (Fig. 4D). VE-cad+CD45- cells failed to form 
hematopoietic colonies after 7 days in methylcellulose culture (Fig. 
3E), but demonstrated hallmark endothelial cell behavior and function 
in vitro, forming capillary tube networks when seeded in basement 
membrane matrix (Fig. 4E). Thus, our separation scheme yields highly 
purified and functional hepatic SEC.
Metabolic and oncogenic stresses increase hepatic MΦ 
and SEC number
To demonstrate the utility of this co-isolation protocol, we eval-
uated the effect of pathologic stresses on hepatic cell populations by 
quantifying the respective frequencies of these cell types in wild type 
mice fed either a high-fat diet (HFD) for 10 weeks or subjected to on-
cogenic stress via exposure to the hepatic-specific chemical carcinogen, 
diethylnitrosamine (DEN). This approach allowed us to efficiently and 
simultaneously dissect the relative contribution of each cell type to the 
resulting phenotype. Whereas HFD and DEN treatment only marginally 
affected PH number, we observed significant increases in hepatic MΦ 
and SEC (Fig. 5A and B). Since there was no significant change in the 
CD45+ or CD45- populations of the NPF under these pathologic con-
ditions (Fig. S5A and B), these fold-change values accurately reflect 
numerical changes in MΦ and SEC within the entire liver.
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Figure 2. The liver parenchymal fraction is enriched for PH expressing CD95. A. Viable PH are isolated by flow cytometry as CD95+ cells of the liver 
parenchymal fraction (green box). B. [i] Visualization of CD95 expression on murine hepatic cells. [ii] and [iii] Fluorescence immunostaining of normal 
murine liver reveals co-expression of CD95 (red) with the mature hepatocyte markers Albumin (Alb, [ii]) and cytokeratin 8 (CK8, [iii]). C. Culture [i] and 
Oil Red O [ii] staining of primary isolated CD95+ PH reveals normal morphology and maintenance of neutral lipid synthesis in vitro. Scale bars = 20 μm. 
See Table S3 for corresponding image magnification. D. Relative expression (fold induction = 1) of hepatocyte-specific genes in CD95+ PH (green bars) 
versus MΦ (blue bars) and SEC (red bars) co-isolated from normal murine liver.
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Figure 3. CD45+ cells of the liver NPF are enriched for F4/80+ tissue-resident MΦ. A. Percentage of liver NPF cells expressing characteristic MΦ 
surface markers within CD45+ and CD45- fractions. B. Distribution of characteristic MΦ surface marker expression on CD45+ cells isolated from NPF. 
C. Immunostaining of murine liver sections demonstrating the expression pattern of F4/80 [i] and its co-expression with CD45 [ii] and CD11b [iii]. Isolated 
F4/80+CD45+ cells exhibit characteristic MΦ morphology in vitro [iv]. Scale bars = 20 μm. See Table S3 for corresponding image magnification. D. [i] In 
vitro hematopoietic colony-forming potential is restricted to isolated liver F4/80+CD45+ cells seeded into methylcellulose medium on fibronectin-coated 
plates. [ii] Isolated tissue-specific F4/80+CD45+ cells from liver NPF formed granulocyte-macrophage colony forming units (CFU-GM) in methylcellulose 
medium. Scale bars = 20 µm. See Table S3 for corresponding image magnification. E. Relative expression (fold induction = 1) of MΦ-associated genes 
is enriched in F4/80+CD45+ cells (blue bars) versus PH (green bars) and SEC (red bars) co-isolated from normal murine liver. F. F4/80+CD45+ MΦ 
up-regulate transcription of inflammatory cytokines upon stimulation with LPS.
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Figure 4. CD45- cells of the liver NPF 
are enriched for VE-cad+ SEC. A. Per-
centage of liver NPF cells expressing SEC 
surface markers within the CD45+ and 
CD45- fractions. B. Distribution of SEC 
surface marker expression on CD45- cells 
from liver NPF. C. Immunostaining of mu-
rine liver sections demonstrates that cells 
lining the sinusoids express VE-cad [i] but 
not CD45 [ii]. VE-cad+ cells also co-ex-
press CD31 [iii]. Isolated tissue-specific 
VE-cad+CD45- cells demonstrate char-
acteristic endothelial cell morphology in 
vitro [iv]. Scale bars = 20 μm. See Table 
S3 for corresponding image magnification. 
D. Relative expression (fold induction=1) 
of SEC-associated genes is enriched in 
VE-cad+CD45- cells (red bars) versus 
PH (green bars) and MΦ (blue bars) 
co-isolated from normal murine liver. E. 
VE-cad+CD45- SEC exhibits capillary 
tube-forming activity in vitro. Scale bar = 
200 μm. See Table S3 for corresponding 
image magnification.
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H&E-stained sections of HFD- and DEN-treated livers revealed areas 
with noticeably increased adipose stores (black arrows), MΦ infiltration 
(blue box), and increased number and/or caliber of sinusoidal vessels (red 
arrows) compared to untreated livers (Fig. 5C). Immunohistochemical 
staining for F4/80 to localize MΦ in both diseased and untreated livers 
confirmed increased F4/80+ MΦ infiltrates in HFD and DEN livers 
compared to untreated controls (Fig. 5C, blue arrows). Similarly, VE-
cad+ SEC (red arrows) lining the hepatic sinusoids showed expansion 
in both number and caliber in HFD- and DEN-treated livers (Fig. 5C). 
Immunohistochemical staining for CD95 suggests negligible changes 
in number of CD95-expressing PH in response to DEN treatment, 
although there appears to be an increase in the expression of CD95 
within hepatic cell types (Fig. 5C).
Metabolic and oncogenic stress induced changes in 
cell-specific transcriptional fingerprints
Our strategy for co-isolation of three liver cell types provides us 
with the ability to analyze cell-specific transcriptional changes upon 
exposure to metabolic or oncogenic stress. We isolated PH, MΦ and 
SEC from HFD- and DEN-treated mice and their untreated (UTR) coun-
terparts, using the protocol outlined in Figure 1B. RNA was isolated 
from each cell preparation and assayed by transcriptomic analyses. 
Hierarchical clustering was applied to compare replicates for each cell 
type under each treatment group, with each replicate represented by a 
pool of cells isolated from 3–4 mice. Each of the three liver cell types 
clustered closely, regardless of treatment (Fig. S5C and D). This initial 
clustering analysis also revealed cassettes of genes whose expression 
either increased or decreased in PH, MΦ, and SEC following HFD or 
DEN treatment (Fig. S5E).
We normalized the HFD and DEN gene expression data relative to 
the UTR control, and again performed hierarchical clustering to deter-
mine gene expression changes that were uniquely and/or commonly 
induced by either stress to each cell type in the liver (Fig. 5D). In PH 
and SEC, DEN treatment elicited a greater number of changes in gene 
expression relative to the UTR control than did HFD, although there 
were a significant number of genes commonly induced or suppressed 
by both pathological stresses (Fig. 5D and Fig. S5F and G). On the 
other hand, the transcriptional responses of MΦ to HFD and DEN were 
nearly identical and show a significant overlap in their gene expression 
profiles (Fig. 5D, Fig. S5F and G).
Gene Set Enrichment Analysis (GSEA) was performed to compare 
the gene signatures of each hepatic cell type to determine how closely 
each hepatic cell type transcriptionally responds to either metabolic 
(HFD) or oncogenic stress (DEN) (Fig. 5E). Genes that were induced 
in HFD-treated PH displayed positive Normalized Enrichment Scores 
(NES) when compared to those induced in DEN-treated PH. Conversely, 
HFD-suppressed PH genes displayed a negative NES when compared 
to DEN-suppressed PH genes. These findings demonstrate close cor-
relation between the transcriptional responses of PH to metabolic and 
oncogenic stress. We observed similar trends for correlation of NES 
scores for hepatic MΦ and SEC exposed to the same challenges (Fig. 
5E), suggesting highly convergent transcriptional responses by these 
key liver cell types when placed under metabolic or oncogenic duress.
Gene ontology (GO) analyses were performed using the gene signa-
tures determined from the HFD- and DEN-treated datasets for PH, MΦ 
and SEC (Fig. 5F). A considerable number of altered pathways shared 
between the HFD- and DEN-treated gene signatures were revealed by 
these analyses. In addition, the robustness of these commonly altered 
pathways clearly reflects the biology of each cell type analyzed. For 
example, GO analysis of PH predominantly revealed alterations in 
metabolic processes, including insulin signaling and diabetes pathways 
(Fig. 5F) whereas HFD- and DEN-treatment altered cytokine signal-
ing and hematopoietic pathways in MΦ. Finally, liver SEC displayed 
transcriptional responses in pathways including eNOS activation and 
regulation as well as tetrahydrobiopterin (BH4) synthesis and regula-
tion, suggesting endothelial cell dysfunction upon exposure to HFD 
or DEN (Fig. 5F).
HFD-suppressed genes in PH, MΦ and SEC correlate 
with down-regulated genes from a human obese liver 
gene set
We also performed GSEA to compare the gene signatures of 
HFD-treated PH, MΦ, and SEC to a human obese liver gene signature 
[20] to determine which, if any, of the three liver cell types possess a 
gene signature that closely recapitulates the gene signature derived from 
unfractionated human liver biopsies. HFD-suppressed genes in PH and 
MΦ displayed negative NES when compared to the down-regulated gene 
signature for a human obese liver dataset (Fig. 6A and B), denoting 
close correlation. However, HFD-induced genes from all three liver cell 
types displayed an inverse correlation with the up-regulated human obese 
liver gene signature (Fig. 6A and B). Since our HFD-treated PH gene 
signature gave a direct correlation when compared to a murine obese 
whole liver gene set [23] (Fig. S6A and B), it is unlikely that the negative 
enrichment scores observed when comparing our murine cell-centric 
data to human obese gene signatures are the result of experimental or 
computational artifacts. Instead, these discrepancies likely reflect the 
inherent variability in human samples as opposed to controlled murine 
obesity models, and of the broad and ill-defined clinical metrics for 
diagnosing obesity. In fact, a cross-comparison of three human obesity 
liver gene signatures [20-22] demonstrated inconsistent correlation of 
gene expression within these available human datasets (Fig. S6C).
Nevertheless, we performed GO analyses using gene signatures 
determined from the HFD- treated PH, MΦ, and SEC datasets and the 
human obese liver gene set [20]. Although only genes down regulated 
in obesity directly correlated with our HFD gene sets, GSEA (Fig. 6A 
and B) revealed a significant number of altered pathways shared be-
tween our HFD-treated data and the human obese liver gene signatures, 
including pathways that not only reflect the biology of the disease (i.e. 
metabolic and inflammatory pathways), but also the biology of each 
respective cell type (Fig. 6C and Fig. S9).
Gene expression signature from DEN-treated PH direct-
ly correlates with a human HCC gene signature
We performed GSEA to compare the gene signatures of DEN-treated 
PH, MΦ, and SEC to a publically available human HCC gene signature 
[18,19]. Of the three liver cell types included in this study, only the PH 
gene signature identically matched the human HCC gene signature (Fig. 
6D and E), consistent with the known pathology of the disease [33,34] 
and mode of action of the chemical carcinogen DEN [35]. Genes that 
are induced by DEN treatment in PH are also highly expressed in HCC, 
whereas DEN-suppressed genes in PH were also down-regulated in the 
human dataset (Fig. 6D and E). Our DEN-treated liver PH gene signa-
ture also directly correlated with the HCC gene profile from Roessler 
et al. [18,19] (Fig. S8C [i], r = 0.59), as well as with a second HCC 
dataset from TCGA-LIHC (Fig. S8C [ii], r = 0.61). These two human 
HCC datasets also demonstrate nearly perfect direct correlation when 
compared with one another (Fig. S8C [iii], r = 0.94).
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Figure 5. Metabolic and oncogenic stresses increase liver MΦ and SEC numbers. A. Frequency of CD95+ PH within the total PF, hepatic F4/80+ 
MΦ within the CD45+ fraction, and VE-cad+ SEC within the CD45- fraction from HFD- and DEN-treated WT mice quantified as fold change relative to 
that observed in an untreated control group (fold change = 1). B. Relative proportions of PH, MΦ, and SEC in untreated, HFD- and DEN-treated livers. 
C. H&E staining and immunohistochemical staining for CD95, F4/80 and VE-cad of liver sections from untreated, HFD- and DEN-treated WT mice. Scale 
bars = 20 μm. See Table S3 for corresponding image magnification. D. Comparative global gene expression patterns in PH, MΦ, and SEC co-isolated 
from HFD- and DEN-treated mice normalized to untreated cell fractions. E. Commonality of gene expression changes observed between PH, MΦ, and 
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SEC isolated from HFD- and DEN-treated murine liver relative to untreated (UTR). F. Association of gene expression signatures of HFD-treated liver PH, 
MP, and SEC with gene signature derived from their corresponding DEN-treated liver cell types. Gene signatures for all three HFD-treated liver cell types 
matched their corresponding DEN-treated gene signatures. G. Normalized enrichment scores (NES) of HFD-induced genes relative to DEN-induced 
genes (UP) and HFD-suppressed genes relative to DEN-suppressed genes (DOWN) from liver PH, MΦ, and SEC determined via the GSEA method. 
H. Commonality of altered pathways determined via Gene Ontology-Biological Pathways functional analyses observed between HFD- and DEN-treated 
PH, MΦ, or SEC. Data show the mean of 2 independent samples of a pool of 3–4 animals.
Figure 6. Gene expression signature from DEN-treated PH matched the gene signature from a human HCC gene set. A. Association of gene 
expression signatures of HFD-treated liver PH, MP, and SEC with gene signature derived from human obese liver biopsies. In all three cell types, only 
the HFD-suppressed gene signatures matched the human obese liver signature [20]. B. Normalized enrichment scores (NES) of HFD-induced (UP) and 
HFD-suppressed (DOWN) genes from liver PH, MΦ, and SEC relative to a human obese liver gene signature [20] via the GSEA method. C. Commonality 
of altered pathways determined via KEGG Pathway functional analyses observed between HFD-treated PH, MΦ, or SEC and human obese liver gene set 
[20]. D. Association of gene expression signatures of DEN-treated liver PH, MΦ, and SEC with gene signature derived from human HCC tumors [18,19]. 
Of all three cell types, only PH demonstrated a gene expression signature (both upregulated and down-regulated) that matched the human HCC signature. 
E. Normalized enrichment scores (NES) of DEN-induced (UP) and DEN-suppressed (DOWN) genes from liver PH, MΦ, and SEC relative to the human 
HCC gene signature [18,19] via the GSEA method. F. Commonality of altered pathways determined via KEGG Pathway functional analyses observed 
between DEN-treated PH, MΦ, or SEC and a human HCC gene set [18,19]. Data show the mean of 2 independent samples of a pool of 3–4 animals.
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GO analyses were performed using gene signatures from DEN-treated 
liver PH, MΦ, and SEC datasets and the human HCC gene set (Fig. 6F, 
Fig. S8A and B). Similar to previous GO analyses we have performed, 
we observed perturbations in pathways common to both our mouse 
datasets and human gene signatures that are characteristic of the disease 
as well as of each respective cell type.
With the aim of understanding not just how these mouse models for 
these diseases correlate with their actual human pathologies, but also 
which transcriptional programs may be initially perturbed and continue 
to persist from a state of metabolic dysfunction through its progression to 
liver cancer, we looked at pathways that were perturbed in all HFD- and 
DEN-treated datasets as well as in the human obese and HCC datasets. 
From here we gain clues as to how external stimuli, specifically met-
abolic insults and hepatocarcinogens, could influence transcriptional 
reprogramming of each of the three liver cell types considered in this 
study (Fig. 7). This data integration clearly illustrates how information 
can be extrapolated from each of the cell-specific datasets in order to 
gain greater insight into the molecular underpinnings for human disease.
In summary, we have developed a highly specific antigen-based cell 
isolation strategy, and demonstrated its practical application for assessing 
the fractional cellular response of three hepatic cell types (i.e. PH, MΦ, 
and SEC) to metabolic and oncogenic stress. On a cellular level, we 
were able to quantify changes in number, distribution, and localization 
of each of these cell types in response to HFD or DEN. We were also 
able to determine the cell-specific and stress-specific transcriptional 
response to HFD and DEN of each cell type using transcriptomic anal-
yses. Perhaps most importantly, we demonstrate the enormous potential 
of acquiring cell-specific gene expression data following fractionation 
of whole tissues, and comparing it to human patient data, to achieve 
a more nuanced understanding of the pathophysiology and biology of 
liver disease.
Figure 7. Model of crosstalk among pathways and hepatic cell types in response to metabolic and oncogenic insult. Some pathways are pre-
dicted to be altered in all 3 cell types. A number of pathways were only altered specifically in PH, MΦ or SEC.
DISCUSSION
We have described an antigen-based isolation procedure that enables 
the simultaneous recovery of three different hepatic cell types with a 
high degree of purity. This strategy is indispensable for assessing not 
only unique and intrinsic cellular properties and functions, but also 
for elucidating how cell-to-cell interactions influence one another 
and contribute to whole-organ biology. This approach is particularly 
important for metabolic tissues like the liver, whose normal activities 
rely upon functional cooperation among distinct cell lineages. These 
findings represent a major advance over previous methods of conducting 
disease-specific gene expression analyses, and eliminates the caveat of 
relying upon data “averages” yielded by the combined contributions 
of all cells within a tissue, a situation that both complicates and over-
simplifies data interpretation by masking the contributions of minority 
cell populations.
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Accurately determining the tissue-specific cell surface phenotype 
of each cell type of interest in this study was essential to improve upon 
existing protocols for isolation of murine hepatic cell types [9,10,36]. 
For instance, we utilized a surface marker to further enrich for CD95+ 
PH in the parenchymal fraction, in comparison to previous studies that 
either use the bulk parenchymal fraction as PH [10], or simply use 
CD95 to assess purity of their hepatocyte preparation [27]. We also 
define hepatic MΦ and SEC using a combination of surface antigens 
that permit more specific cell preparations, with MΦ expressing both 
F4/80 and CD45, and SEC expressing VE-cadherin, but not CD45. 
Lastly, incorporation of flow cytometric analysis presents another 
advantage and utility to our approach, because it allows quantitative 
assessment of absolute cell number and relative frequencies, especially 
under pathological conditions.
Obesity and chronic liver diseases, including hepatocellular carcino-
ma, share surprisingly similar epidemiology [4,5], as well as altered gene 
expression and metabolism in a number of common cell types including 
PH, MΦ, and SEC. Characterized as a chronic, low-grade inflammatory 
disease, obesity is a risk factor for HCC as chronic inflammation drives 
liver cancer progression and metastasis [4,5]. Hepatocytes in a chronic 
inflammatory environment become more apoptotic, activate tissue-res-
ident MΦ, and recruit other inflammatory cells, which then switch to a 
pro-inflammatory state. Chemokines secreted by these activated cells 
act in paracrine and autocrine manners to promote insulin resistance and 
tumorigenesis [4,5]. Using established experimental mouse models for 
obesity and liver cancer, we examined PH, MΦ, and SEC in HFD and 
DEN-treated mice using the isolation procedure detailed in this study, 
to decipher how these stress conditions influence cellular composition 
and global gene expression within the liver.
Consistent with previous reports, we observed an increase in hepatic 
MΦ number in both HFD and DEN-treated states [37-40]. Microarray 
analyses revealed that overlap of gene expression signatures between 
the two treatments is considerable, with significant alterations pre-
dominantly in inflammatory and stress response pathways. The exact 
molecular mechanisms underlying the transcriptional changes in MΦ 
and how they contribute to the cellular phenotype as reflected in our 
histological analyses represent promising areas for future study.
Endothelial cell dysfunction is a hallmark of metabolic syndrome 
and chronic liver disease, and is a key driver in their pathogenesis and 
progression [41,42]. HCC represents one of the most highly vascular-
ized (“angiogenic”) solid tumors [41], and DEN-treated mice display 
increased liver angiogenesis; as such, strategic targeting of pro-angio-
genic factors has become a major focus of solid cancer therapeutics 
[39,43,44]. From our observations we have determined that there is a 
marked increase in hepatic VE-cad+CD45- SEC in mice subjected to 
either HFD or DEN, and histological evidence suggests an expanded but 
leaky vasculature in the liver. While our GO analyses reveal alterations 
in angiogenic, eNOS signaling, and regulatory BH4 pathways suggest-
ing endothelial cell dysfunction, the extent to which SEC functionality 
either responds to or drives these pathological states still remains to be 
clarified. Together, these data suggest that the molecular etiology of 
these two disease states not only involves the same cell type responses, 
but that cell-specific programs activated under excess caloric stress are 
fundamentally relevant to the cellular response to oncogenic stress.
The importance and utility of the technical advance presented here 
was demonstrated by interrogating liver cell-specific responses to two 
closely related pathological insults, HFD and DEN. The power of this 
technique not only highlights our ability to quantify changes in cell 
number in the liver and via flow cytometry, but also to collect highly 
purified, live, intact fractions of each cell type for downstream analyses. 
Transcriptomic profiling revealed dramatic gene expression changes 
induced by HFD or DEN that are specific to each cell type in the liver. 
For instance, liver PH and SEC responded more robustly to DEN than 
HFD, while hepatic MΦ responded almost identically to both stressors. 
Such changes in gene expression can only be appreciated by collecting 
phenotypically defined cell fractions, and would be lost if these analyses 
were performed using whole, unfractionated tissues.
Perhaps one of the more important contributions of our improved 
technical approach is that it provides a template for obtaining cell- and 
tissue-specific gene expression data, which can be used to interrogate 
gene signatures from known human pathologies. The fact that the 
murine PH DEN gene signature correlates strongly with the human 
HCC signature is somewhat expected, considering the known etiolo-
gy of the disease and the relative abundance of hepatocytes to other 
contributing lineages [35]. However, this was not the case for the HFD 
comparison to the human obese dataset. Although the discrepancy may 
be due in part to differences in diagnostic criteria for staging human 
obesity versus HCC, it also highlights the fact that our knowledge of 
the contributions of non-hepatocyte cells to liver disease is significantly 
lacking, and emphasizes the utility of our fractionation technique to aid 
in deciphering the specific contribution of minority cell types to the 
overarching tissue-specific gene signature. HCC diagnosis and staging 
is most accurately defined via pathological standards that present more 
reliable criteria [34]. Our comparative analysis of multiple human obesity 
and HCC datasets reflects this fact, showing poor correlation between 
available obesity data, yet demonstrating nearly perfect correlation 
with two public HCC gene signatures (TCGA-LIHC and [18,19]). In 
all, these comparisons demonstrate the need to determine cell-specific 
contributions, as opposed to whole-tissue profiling, to better understand 
the pathobiology of human diseases.
We have made available a tool for future investigators interested in 
hepatic biology to assess, characterize, and deconvolute PH-, MΦ-, and 
SEC-specific responses to practically any experimental or physiologic 
stimulus, administered either in vivo or in vitro. This study also provides 
a much needed cell-specific gene expression array resource that can be 
exploited to understand the mechanisms underlying: (1) the tissue-specific 
biology of PH, MΦ and SEC; (2) the pathology of obesity and HCC in 
the context of their respective murine models; and (3) interactions that 
exist amongst cells within their native or diseased states.
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